The Book of Peptides
PeptidesStacksKnowledgeNewsletterBooks
Log in
The Book of Peptides

An interactive reference for people who want to be fully conscious of what they're doing. Educational — not medical advice.

Reference
  • Peptides
  • Stacks
  • Knowledge
Product
  • Books & membership
  • Newsletter
  • Account
Trust
  • Our methodology
  • About
  • FAQ
Not medical advice

The Book of Peptides is not a clinic and not your doctor. We do not sell, prescribe, recommend, or personalize any compound, and no grade or ranking here is an endorsement. In the United States, most of these compounds are not FDA-approved and are sold for laboratory research only; a few are prescription drugs, and some are controlled substances or banned in sport. Possessing or administering an unapproved compound outside an authorized setting may be unlawful. Nothing here is a recommendation to buy, possess, or self-administer anything. Consult a licensed physician before any decision involving peptide use.

© 2026 The Book of Peptides. For educational and harm-reduction purposes only. Not medical advice.PrivacyTerms
Book Two · Combination protocols

Stacks & synergy

26 combination protocols — what genuinely pairs with what, the mechanism behind why, and how scheduling shifts when compounds run together rather than solo. Grouped by goal.

Protocols
26
Categories
9
Compounds combined
55
Metabolic & Fat-Loss Stacks
T1 · Established

CagriSema (Cagrilintide + Semaglutide)

Cagrilintide + Semaglutide

A fixed 1:1 combination designed to produce superior, sustained weight loss (and, in type-2 diabetics, superior HbA1c reduction) versus either drug alone, by pairing two mechanistically distinct satiety pathways in one lockstep weekly regimen — this is Novo Nordisk's own designed and trial-tested purpose for the pairing, not a community-improvised stack.

Cagrilintide (long-acting amylin/calcitonin receptor agonist)Semaglutide (GLP-1 receptor agonist)hybrid
T4 · Theoretical

Cagrilintide + Tirzepatide

Cagrilintide + Tirzepatide

Stack a long-acting amylin agonist onto tirzepatide's dual GIP/GLP-1 action to push fat-loss and metabolic-marker improvement beyond either compound alone, in principle allowing lower per-drug doses for the same or better effect.

CagrilintideTirzepatidestack
T3 · Emerging

Retatrutide + Cagrilintide ("Quad-Pathway" stack)

Retatrutide + Cagrilintide

Layers cagrilintide's amylin-pathway satiety signal onto retatrutide's triple GLP-1/GIP/glucagon mechanism to hit four non-overlapping metabolic pathways at once — the aim is greater total fat loss, more complete appetite control, and the option to run each compound at a lower, better-tolerated dose.

Retatrutide (LY3437943) — triple GLP-1/GIP/glucagon receptor agonist (Eli Lilly, investigational, Phase 3 TRIUMPH program)Cagrilintide — long-acting amylin/calcitonin receptor agonist (Novo Nordisk, investigational as monotherapy; Phase 3 as CagriSema with semaglutide)stack
T4 · Theoretical

The Layered Lipolysis Stack

Semaglutide/Tirzepatide/Retatrutide + AOD-9604

To layer adipocyte-level lipolysis on top of an existing weekly GLP-1/GIP agonist, chasing fat loss that doesn't depend on further appetite suppression — marketed as a "finishing phase" add-on for a stalled plateau or the last few stubborn pounds, not a starting-point protocol.

Semaglutide (or Tirzepatide, or Retatrutide) — weekly GLP-1/GIP agonistAOD-9604 — daily fasted modified hGH fragment 176-191stack
GH Secretagogue Stacks
T3 · Emerging

Tesamorelin + Ipamorelin

Tesamorelin + Ipamorelin

Amplifies and normalizes the body's own nighttime growth-hormone pulses to support visceral-fat reduction, lean-mass-preserving recomposition, and recovery/skin quality — the two peptides are stacked because they act on two separate, complementary nodes of the GH-release axis rather than duplicating each other's effect.

Tesamorelin (Egrifta) — GHRH analogIpamorelin — selective ghrelin-receptor (GHS-R1a) GHRPstack
T3 · Emerging

Sermorelin + GHRP-6

Sermorelin + GHRP-6

Pair a GHRH analog with a ghrelin-mimetic GHRP to drive a stronger natural GH/IGF-1 pulse than either compound produces alone -- targeting muscle gain, fat loss, recovery, and sleep quality -- while GHRP-6 specifically adds a pronounced appetite-stimulating effect useful for bulking (or, for some users, an unwanted side effect they'd rather avoid by switching to GHRP-2 or ipamorelin).

Healing & Recovery Stacks
T4 · Theoretical

Wolverine Stack (BPC-157 + TB-500)

BPC-157 + TB-500

Accelerated soft-tissue and musculoskeletal healing — tendon, ligament, muscle, and joint injuries, plus post-surgical recovery — by pairing two peptides that vendor, clinic, and forum sources consistently describe as acting on different stages of the repair cascade rather than duplicating one another.

BPC-157 (Body Protection Compound-157, stable gastric pentadecapeptide)TB-500 (synthetic fragment corresponding to the active region of Thymosin Beta-4 / Tβ4)stack
T4 · Theoretical

BPC-157 + KPV (Gut-Healing Duo)

BPC-157 + KPV

A gut-specific pairing that combines a mucosal "repair" peptide with a targeted anti-inflammatory tripeptide, marketed for leaky gut, IBS, and IBD/colitis-adjacent symptoms rather than the tendon/ligament use case BPC-157 is better known for.

Muscle-Building Stacks
T4 · Theoretical

CJC-1295 (no DAC) + Ipamorelin

CJC-1295 (no DAC) + Ipamorelin

A GH-axis "base layer" stack that pairs a GHRH analog with a selective ghrelin-receptor agonist to raise endogenous GH/IGF-1 pulses more strongly than either compound alone, aimed at recovery, sleep quality, and body composition rather than acting as a muscle-building compound in its own right.

CJC-1295 (without DAC) / Mod GRF 1-29Ipamorelinstack
T3 · Emerging

IGF-1 LR3 + CJC-1295/Ipamorelin

IGF-1 LR3 + CJC-1295 (no DAC) + Ipamorelin

A three-peptide "full GH/IGF-1 axis" stack meant to hit the same growth-signaling pathway from two directions at once: CJC-1295 + Ipamorelin drive a bigger, more frequent pulse of the body's own growth hormone (and the downstream IGF-1 rise that follows it), while IGF-1 LR3 is injected directly to activate IGF-1 receptors in trained muscle immediately, without waiting on the GH step.

Longevity & Cellular Health Stacks
T3 · Emerging

Epitalon + GHK-Cu

Epitalon (Epithalon) + GHK-Cu

A "two-pathway" longevity pairing that couples Epitalon's proposed nuclear/genomic action (telomerase activity, chromatin, pineal-melatonin rhythm) with GHK-Cu's better-established extracellular-matrix and tissue-repair action (collagen synthesis, broad gene-expression modulation) — the pitch being that one covers "inside the nucleus" aging and the other covers "structural/dermal-repair" aging, so a general anti-aging user runs both to cover more ground than either alone.

Epitalon / Epithalon (synthetic tetrapeptide Ala-Glu-Asp-Gly, AEDG)GHK-Cu (glycyl-L-histidyl-L-lysine copper(II) complex)stack
T3 · Emerging

Epitalon + Thymosin Alpha-1

Epitalon (Epithalon) + Thymosin Alpha-1 (TA1)

Sexual Health & Hormonal Stacks
T4 · Theoretical

"PT-141 + Melanotan II"

"PT-141 + Melanotan II"

Pairs MT-2's broad melanocortin activation (tanning plus incidental libido) with PT-141's on-demand sexual-response boost — both hit the same receptor family, so this isn't really combining two different effects, and most experienced users report picking one or the other by season rather than truly stacking them for combined intensity.

PT-141 (Bremelanotide)Melanotan IIstack
T3 · Emerging

PT-141 (Bremelanotide) + Oxytocin + Tadalafil

PT-141 + Oxytocin + Tadalafil ("Olympus")

A three-lever "complete" sexual-wellness troche marketed to hit central desire (PT-141), emotional bonding/connection (oxytocin), and peripheral erectile blood flow (tadalafil) in a single as-needed dose — but forum reports on the actual compounded troche are notably more mixed than the vendor copy selling it.

Immune-Modulating Stacks
T4 · Theoretical

Thymosin Alpha-1 + LL-37

Thymosin Alpha-1 + LL-37

Broad-spectrum, "layered" immune support pairing a slow-acting adaptive-immune coordinator (Thymosin Alpha-1, which primes T-cells and NK cells over days-to-weeks) with a fast-acting innate antimicrobial (LL-37, which physically disrupts pathogen membranes on contact). Framed by users as seasonal/preventive support and an adjunct during active infection, not as treatment for any diagnosed disease.

Thymosin Alpha-1 (Tα1, brand name Zadaxin/thymalfasin)LL-37 (human cathelicidin antimicrobial peptide, cleaved from hCAP18)stack
T4 · Theoretical

Thymosin Alpha-1 + TB-500

Thymosin Alpha-1 + TB-500 (Thymosin Beta-4)

Pairs immune reconstitution with accelerated soft-tissue repair on the logic that the two jobs don't compete for the same biology — used for post-illness deconditioning, post-surgical recovery, and combined immunosenescence plus musculoskeletal decline. It is explicitly not a bodybuilding or performance stack.

Kitchen-Sink Mega-Blends
T4 · Theoretical

KLOW

GHK-Cu + BPC-157 + TB-500 + KPV

Sold as an all-in-one soft-tissue repair blend for tendon, ligament, muscle, joint, and gut/gastric irritation, with the KPV addition specifically framed as layering systemic anti-inflammatory action on top of the GLOW (GHK-Cu + BPC-157 + TB-500) base formula. The appeal is a "repair timeline" narrative -- revascularize, recruit repair cells, rebuild matrix, then suppress the inflammation that would otherwise stall the process -- rather than any single compound addressing the whole chain.

GHK-CuBPC-157TB-500KPVblend
T4 · Theoretical

GLOW (GHK-Cu + BPC-157 + TB-500)

Cognitive & Neuroprotective Stacks
T3 · Emerging

Semax + Selank

"Russian Nootropic Stack" · Semax + Selank

Pairs Semax's alerting, BDNF-driven cognitive lift with Selank's non-sedating anxiolysis, aiming for calm, sustained focus without stimulant jitteriness or benzo-style blunting. Commonly run by people who found Semax alone too activating, or Selank alone insufficiently stimulating.

Semax (heptapeptide, ACTH(4-10) analog, MEHFPGP) or N-Acetyl Semax Amidate variantSelank (heptapeptide, Tuftsin analog, TKPRPGP) or N-Acetyl Selank Amidate variantstack
SermorelinGHRP-6stack
T3 · Emerging

CJC-1295 (no DAC) + Hexarelin

CJC-1295 (no DAC) + Hexarelin

Pairs a GHRH-receptor agonist with the single most potent GHRP available to produce a genuinely synergistic (not just additive) GH pulse, for people already comfortable with solo GH secretagogues who want the strongest acute pulse this drug class can produce — accepting a short usable cycle window as the tradeoff.

CJC-1295 (no DAC) / Mod GRF 1-29Hexarelinstack
BPC-157 (Body Protection Compound-157, stable gastric pentadecapeptide)KPV (Lys-Pro-Val tripeptide, C-terminal fragment of alpha-MSH)stack
T4 · Theoretical

Gut Inflammation Trio

BPC-157 + KPV + Larazotide

An oral, three-mechanism gut-inflammation and intestinal-barrier ("leaky gut") support stack aimed at people with IBD-adjacent symptoms, food-reactivity, or post-NSAID/post-infectious gut irritation. The stacking rationale is division of labor: Larazotide is claimed to shore up the tight-junction barrier, KPV to calm the cytokine cascade already triggered, and BPC-157 to drive the underlying tissue repair — "prevent, calm, rebuild" rather than one compound doing all three jobs.

BPC-157 (pentadecapeptide, gastric-juice derived; sold in these blends as the more stable "BPC-157 arginate" salt in at least one product line)KPV (Lys-Pro-Val tripeptide, C-terminal fragment of alpha-MSH)Larazotide acetate / AT-1001 (marketed in these blends as "N-Acetyl Larazotide"; synthetic octapeptide, zonulin-pathway antagonist)stack
IGF-1 LR3CJC-1295 (no DAC)Ipamorelinstack
T3 · Emerging

MK-677 (Ibutamoren) + IGF-1 LR3

MK-677 + IGF-1 LR3

Pairs a daily oral GH-secretagogue (MK-677) that keeps systemic GH/IGF-1 chronically elevated with an injected IGF-1 analog (LR3) that delivers an acute, high-concentration local bolus post-workout — the idea being to cover both the "always-on" systemic baseline and the "spike-on-demand" local signal in one stack.

MK-677 (Ibutamoren)IGF-1 LR3 (Long R3 IGF-1)stack

Cover two non-overlapping decline pathways at once: Epitalon targets the pineal/circadian-melatonin axis and proposed telomere biology, while Thymosin Alpha-1 targets thymic involution and age-related loss of T-cell immune competence. The pairing is chosen because each compound addresses a different system, not because either boosts the other.

Epitalon (Epithalon)Thymosin Alpha-1 (TA1)stack
T3 · Emerging

GHK-Cu + NAD+

GHK-Cu + NAD+ (or NMN/NR)

Pair two longevity compounds that work on completely separate biological layers — GHK-Cu remodeling skin/tissue collagen, NAD+ refueling mitochondrial energy and DNA-repair enzymes — so a single protocol addresses both skin/hair/wound quality and energy/cognition at once.

GHK-Cu (copper tripeptide GHK-Cu)NAD+ (direct injection/IV, or precursors NMN/NR oral)stack
T3 · Emerging

Thymalin + Epitalon (Khavinson Stack)

Thymalin + Epitalon (Epithalamin)

Pairs a thymic-immune bioregulator with a pineal-neuroendocrine bioregulator as a seasonal "two-axis" longevity course, run together because the founding human trial itself found the combination beat either compound alone on its mortality endpoint (2.5-fold combined vs. 2.0-2.1-fold for Thymalin alone and 1.6-1.8-fold for Epithalamin alone).

Thymalin (thymic polypeptide bioregulator, calf-thymus extract or pharmaceutical-brand equivalent)Epitalon / Epithalamin (Ala-Glu-Asp-Gly synthetic tetrapeptide, or the original bovine pineal polypeptide extract it was derived from)stack
PT-141 (Bremelanotide) — cyclic heptapeptide, MC3R/MC4R melanocortin receptor agonist, FDA-approved as Vyleesi (SC injection only) for HSDD in premenopausal womenOxytocin — synthetic nonapeptide, oxytocin receptor agonist ('bonding hormone'), off-label/compounded, not FDA-approved for this indication via any routeTadalafil — PDE5 inhibitor, FDA-approved generic (Cialis) for ED/BPH/PAH — the only component with genuinely robust independent RCT backing for a sexual-health indicationblend
T3 · Emerging

Olympus (PT-141 + Oxytocin)

Bremelanotide 1-2mg + Oxytocin 20-40IU, sublingual, no tadalafil

Combines PT-141's central desire/arousal effect with oxytocin's bonding/intimacy effect in a single sublingual tablet, deliberately without a PDE5 inhibitor — for people whose complaint is low desire or emotional disconnection rather than erectile blood flow, or who want to avoid stacking a third agent onto bremelanotide's own transient blood-pressure effect.

Bremelanotide (PT-141)Oxytocinblend
Thymosin Alpha-1 (Tα1)TB-500 (Thymosin Beta-4 fragment, Ac-LKKTETQ)stack

GHK-Cu + BPC-157 + TB-500

A three-peptide "regenerative" blend sold as the KPV-free predecessor to KLOW, marketed to cover surface skin quality and deeper soft-tissue repair at once: GHK-Cu for collagen/elastin remodeling, BPC-157 for localized tendon/ligament and gut-lining repair, and TB-500 for systemic cell-migration and anti-inflammatory support with reduced scarring.

GHK-Cu (copper tripeptide-1)BPC-157 (Body Protection Compound-157)TB-500 (vendor synthetic Thymosin Beta-4 fragment)blend
T4 · Theoretical

GH Secretagogue Triple Blend

CJC-1295 (No DAC) + Ipamorelin + Tesamorelin

Layers Tesamorelin's on-label, trial-proven visceral-fat-reduction GHRH signal on top of the simpler CJC-1295+Ipamorelin GH-pulse stack, marketed as an escalation product for users who specifically want a fat-targeted GHRH agent added rather than just more of the same non-selective GHRH tone.

CJC-1295 (No DAC / Mod GRF 1-29)IpamorelinTesamorelinblend